missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cytiva HiTrap™ MabSelect™ SuRe™ LX Columns
Sfoglia Tutto Cytiva Prodotti
missing translation for 'orderingAttributeHoverText'
Quantity:
10/Pk.
5/Pk.
Volume (Metric) Bed:
1 mL
5 mL
missing translation for 'unitSize'
Pack of 10
Pack of 5
Descrizione
- Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH
- High dynamic binding capacity (DBC) for high titer cultures reduces process time and amount of medium used
- Generic elution profile for different monoclonal antibodies enables platform approach to purification
- High-flow agarose matrix allows the processing of large feed volumes
- Reduces the risk of product contamination and carryover
- Improves performance and reduces overall costs
Specifica
Specifica
| Product Type | Antibody Purification Column |
| Stationary Phase | MabSelect SuRe LX |
| Flow Rate | 4 mL/min. (Max) |
| Ligand | Protein A |
| Particle Size | 85 μm |
| Purification Target | Human IgG |
| Volume (Metric) Bed | 1 mL |
| For Use With (Application) | Purification of Human IgG |
| Sample Volume | 1 to 30 mg/Column |
| Quantity | 5/Pk. |
Sicurezza e movimentazione
Identificativo prodotto
- HiTrap MabSelect SuRe LX
- Warning
- Flammable liquid Category 3
- H226-Flammable liquid and vapour.
- P241-Use explosion-proof electrical/ventilating/lighting/ equipment.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
- MIXTURE LIST-Contains : ethanol
- UNKNOWN ACUTE-16.5 per cent of the mixture consists of component(s) of unknown acute toxicity.
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto